欧洲儿童重症监护病房连续肾脏替代治疗实践调查
该横断面调查由欧洲儿科与新生儿重症监护学会重症肾脏病学组开展,2020年4月1日至2022年5月31日覆盖20个欧洲国家PICU,收到283份回复、纳入161份(回复率76%)。结果显示:CKRT处方主要由PICU主治医师(70%)和PICU团队(77%)负责,护士负责管路预充(49%)和床旁机器运行(67%);61%的固定护士接受过CKRT培训,36%的PICU无需认证或再认证;连续静脉-静脉血液透析滤过为首选模式(51%);新生儿中位CKRT剂量35(30-50)mL/kg/h,1月龄至18岁儿童30(30-40)mL/kg/h。抗凝以区域普通肝素输注(41%)和枸橼酸区域抗凝(35%)为主。作者认为当前CKRT实践差异广泛,呼吁儿科重症与肾脏病学界协同统一教育培训、研究和指南以减少差异。
要点
- 新生儿CKRT中位剂量35(30-50)mL/kg/h,1月龄至18岁儿童30(30-40)mL/kg/h。
- 连续静脉-静脉血液透析滤过为首选透析模式(51%);管路预充用生理盐水(67%),体重<10 kg儿童用血液预充(56%)。
- 区域抗凝:41%的PICU使用普通肝素输注,35%使用枸橼酸区域抗凝。
- 滤器更换指征为滤器凝血(53%)和跨膜压升高(47%);62%的PICU常规管路更换截止时间为72小时。
- 34%的PICU每4小时监测液体清除目标,液体清除目标范围1-3 mL/kg/h;脱机采用利尿剂弹丸后输注(32%)或单用利尿剂弹丸(19%)。
适用人群与场景
- 欧洲20个国家收治并开展CKRT的PICU,由PICU主治医师和护士填写问卷;每个开展CKRT的PICU纳入一份回复。
处置流程与药物剂量
- CKRT处方主要由PICU主治医师(70%)和PICU团队(77%)负责,护士负责管路预充(49%)和床旁机器运行(67%)。
- 61%的固定护士接受过CKRT使用培训,36%的PICU无需认证或再认证。
- 首选透析模式为连续静脉-静脉血液透析滤过(51%);管路预充用生理盐水(67%),体重<10 kg儿童用血液预充(56%)。
- 新生儿CKRT中位剂量35(30-50)mL/kg/h,1月龄至18岁儿童30(30-40)mL/kg/h。
- 区域抗凝:41%的PICU使用普通肝素输注,35%使用枸橼酸区域抗凝。
- 滤器更换指征为滤器凝血(53%)和跨膜压升高(47%);62%的PICU常规管路更换截止时间为72小时。
- 34%的PICU每4小时监测液体清除目标,12小时监测占17%、24小时监测占13%;液体清除目标范围1-3 mL/kg/h。
- 脱离CKRT采用利尿剂弹丸后输注(32%)或单用利尿剂弹丸(19%)。
研究设计与关键结果
- 研究类型:横断面调查;制定机构:欧洲儿科与新生儿重症监护学会重症肾脏病学组;时间:2020年4月1日至2022年5月31日;覆盖20个欧洲国家PICU。
- 共收到283份调查回复,纳入161份分析(回复率76%)。
- CKRT处方责任:PICU主治医师70%、PICU团队77%;护士负责管路预充49%、床旁机器运行67%。
- 培训与认证:61%的固定护士接受过CKRT培训,36%的PICU无需认证或再认证。
- 透析模式:连续静脉-静脉血液透析滤过为首选(51%)。
- 预充:生理盐水67%,体重<10 kg儿童血液预充56%。
- 剂量:新生儿中位35(30-50)mL/kg/h,1月龄至18岁儿童30(30-40)mL/kg/h。
- 抗凝:区域普通肝素输注41%,枸橼酸区域抗凝35%;滤器更换指征为滤器凝血53%、跨膜压升高47%;62%的PICU常规管路更换截止时间为72小时;34%的PICU每4小时监测液体清除目标(12小时17%、24小时13%),液体清除目标1-3 mL/kg/h;脱机采用利尿剂弹丸后输注32%或单用利尿剂弹丸19%。
证据类型、等级与局限
- 证据类型:横断面调查(欧洲儿科与新生儿重症监护学会重症肾脏病学组开展)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 调查显示欧洲PICU的CKRT实践在组织管理、教育培训、处方和脱机方面存在广泛差异,作者呼吁儿科重症与肾脏病学界协同努力统一CKRT教育培训、研究和指南以减少实践差异。
指南或共识出处
- 欧洲儿科与新生儿重症监护学会重症肾脏病学组(Critical Care Nephrology Section of the European Society of Pediatric and Neonatal Intensive Care)调查,2020年4月1日至2022年5月31日。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Continuous kidney replacement therapy (CKRT) is the preferred method of kidney support for children with critical illness in pediatric intensive care units (PICUs). However, there are no data on the current CKRT management practices in European PICUs.
OBJECTIVE: To describe current CKRT practices across European PICUs.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional survey of PICUs in 20 European countries was conducted by the Critical Care Nephrology Section of the European Society of Pediatric and Neonatal Intensive Care from April 1, 2020, to May 31, 2022. Participants included intensivists and nurses working in European PICUs. The survey was developed in English and distributed using SurveyMonkey. One response from each PICU that provided CKRT was included in the analysis. Data were analyzed from June 1 to June 30, 2022.
MAIN OUTCOME AND MEASURES: Demographic characteristics of European PICUs along with organizational and delivery aspects of CKRT (including prescription, liberation from CKRT, and training and education) were assessed.
RESULTS: Of 283 survey responses received, 161 were included in the analysis (response rate, 76%). The attending PICU consultant (70%) and the PICU team (77%) were mainly responsible for CKRT prescription, whereas the PICU nurses were responsible for circuit setup (49%) and bedside machine running (67%). Sixty-one percent of permanent nurses received training to use CKRT, with no need for certification or recertification in 36% of PICUs. Continuous venovenous hemodiafiltration was the preferred dialytic modality (51%). Circuit priming was performed with normal saline (67%) and blood priming in children weighing less than 10 kg (56%). Median (IQR) CKRT dose was 35 (30-50) mL/kg/h in neonates and 30 (30-40) mL/kg/h in children aged 1 month to 18 years. Forty-one percent of PICUs used regional unfractionated heparin infusion, whereas 35% used citrate-based regional anticoagulation. Filters were changed for filter clotting (53%) and increased transmembrane pressure (47%). For routine circuit changes, 72 hours was the cutoff in 62% of PICUs. Some PICUs (34%) monitored fluid removal goals every 4 hours, with variation from 12 hours (17%) to 24 hours (13%). Fluid removal goals ranged from 1 to 3 mL/kg/h. Liberation from CKRT was performed with a diuretic bolus followed by an infusion (32%) or a diuretic bolus alone (19%).
CONCLUSIONS AND RELEVANCE: This survey study found a wide variation in current CKRT practice, including organizational aspects, education and training, prescription, and liberation from CKRT, in European PICUs. This finding calls for concerted efforts on the part of the pediatric critical care and nephrology communities to streamline CKRT education and training, research, and guidelines to reduce variation in practice.
参考来源
- Daverio M, Cortina G, Jones A, et al. Continuous Kidney Replacement Therapy Practices in Pediatric Intensive Care Units Across Europe. JAMA Netw Open. 2022. PMID: 36520438. doi:10.1001/jamanetworkopen.2022.46901
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。